Helicobacter pylori infection overview: Difference between revisions

Jump to navigation Jump to search
Yamuna Kondapally (talk | contribs)
Yamuna Kondapally (talk | contribs)
Line 4: Line 4:


==Overview==
==Overview==
'''''Helicobacter pylori''''' ('''''H. pylori'''''), previously named '''''Campylobacter pyloridis''''', is a [[gram-negative]], [[microaerophile|microaerophilic]] [[bacterium]] found in the [[stomach]]. It is also linked to the development of [[duodenum|duodenal]] ulcers and [[stomach cancer]]. However, over 80 percent of individuals infected with the bacterium are [[asymptomatic]] and it has been postulated that it may play an important role in the natural stomach ecology.<ref>{{Cite journal
Helicobacter pylori infection is a common worldwide human infectios. It is caused by H.pylori bacteria which is a gram negative, microaerophilic, and acidophilic bacterium that infects various areas stomach and duodenum. The infection is associated with number a number of upper gastrointestinal conditions like chronic gastritis, peptic ulcer disease, and gastric malignancy. It is more common in developing countries than developed countries. It is estimated that 30-40% of the US population are infected with H.pylori.
| last1 = Blaser | first1 = M. J.
| title = Who are we? Indigenous microbes and the ecology of human diseases
| doi = 10.1038/sj.embor.7400812
| journal = EMBO Reports
| volume = 7
| issue = 10
| pages = 956–60
| year = 2006
| pmid = 17016449
| pmc =1618379
| url = http://www.nature.com/embor/journal/v7/n10/pdf/7400812.pdf
}}</ref>
 
More than 50% of the world's population harbor ''H. pylori'' in their upper [[gastrointestinal tract]]. Infection is more prevalent in developing countries, and incidence is decreasing in Western countries. ''H. pylori'''s helix shape (from which the [[genus|generic]] name is derived) is thought to have evolved to penetrate the [[mucus|mucoid]] lining of the stomach.<ref name= YamaokaY>{{cite book
|author=Yamaoka, Yoshio
|title=Helicobacter pylori: Molecular Genetics and Cellular Biology
|publisher=Caister Academic Pr
|year=2008
|isbn=1-904455-31-X
}}</ref><ref name="Brown">{{cite journal
|author=Brown LM
|title=Helicobacter pylori: epidemiology and routes of transmission
|journal=Epidemiol Rev
|volume=22
|issue=2
|pages=283–97
|year=2000
|pmid=11218379
|doi=
|url=http://epirev.oxfordjournals.org/content/22/2/283.full.pdf
}}</ref>


==Historical Perspective==
==Historical Perspective==

Revision as of 17:22, 16 January 2017

Helicobacter pylori infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Gastritis
Peptic ulcer disease
Gastric adenocarcinoma
MALT lymphoma

Causes

Differentiating Helicobacter pylori infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Guideline Recommendation

ACG guidelines
ESPGHAN and NASPGHAN guidelines

History and Symptoms

Physical Examination

Diagnostic tests

Endoscopic tests
Nonendoscopic tests

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Helicobacter pylori infection overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Helicobacter pylori infection overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Helicobacter pylori infection overview

CDC on Helicobacter pylori infection overview

Helicobacter pylori infection overview in the news

Blogs on Helicobacter pylori infection overview

Directions to Hospitals Treating Helicobacter pylori infection

Risk calculators and risk factors for Helicobacter pylori infection overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]

Overview

Helicobacter pylori infection is a common worldwide human infectios. It is caused by H.pylori bacteria which is a gram negative, microaerophilic, and acidophilic bacterium that infects various areas stomach and duodenum. The infection is associated with number a number of upper gastrointestinal conditions like chronic gastritis, peptic ulcer disease, and gastric malignancy. It is more common in developing countries than developed countries. It is estimated that 30-40% of the US population are infected with H.pylori.

Historical Perspective

The association between helicobacter pylori and peptic ulcers was made by Barry Marshall and Ribin Warren in the year 1984 for which they were awarded with Nobel prize in 2005 in physiology or medicine.

Pathophysiology

Helicobacter pylori (H. pylori) is a bacterium that lives on the lining of the stomach. Although we used to think that spicy food, acid, and stress were the major causes of ulcers, we now know that nine out of ten ulcers are caused by H. pylori. Medicines that reduce stomach acid may make you feel better, but your ulcer may come back. Here's the good news: Since most ulcers are caused by this bacterial infection, they can be cured with the right antibiotics.

Causes

Helicobacter pylori infection is caused by H.pylori bacterium.

Epidemiology and Demographics

Approximately two-thirds of the world's population is infected with H. pylori. In the United States, H. pylori is more prevalent among older adults, African Americans, Hispanics, and lower socioeconomic groups.

Approximately 25 million Americans suffer from peptic ulcer disease at some point in their lifetime. Each year there are 500,000 to 850,000 new cases of peptic ulcer disease and more than one million ulcer-related hospitalizations.

Risk Factors

Common risk factors in the development of H.pylori infection are contaminated food and water, poor hygiene, over crowding, lower socio-economic status, smoking, age and race.

Screening

According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for H.pylori infection.

Treatment

Medical Therapy

Persons with active gastric or duodenal ulcers or documented history of ulcers should be tested for H. pylori, and if found to be infected, they should be treated. To date, there has been no conclusive evidence that treatment of H. pylori infection in patients with non-ulcer dyspepsia is warranted. Testing for and treatment of H. pylori infection are recommended following resection of early gastric cancer and for low-grade gastric MALT lymphoma. Retesting after treatment may be prudent for patients with bleeding or otherwise complicated peptic ulcer disease. Treatment recommendations for children have not been formulated. Pediatric patients who require extensive diagnostic work-ups for abdominal symptoms should be evaluated by a specialist.

Primary Prevention

Since the source of H. pylori is not yet known, recommendations for avoiding infection have not been made. In general, it is always wise for persons to wash hands thoroughly, to eat food that has been properly prepared, and to drink water from a safe, clean source.

References

Template:WH Template:WS